Paper27445162
Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis.
Kalim S and 8 others. Clin J Am Soc Nephrol, 2016. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis. Papers, record 27445162. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27445162
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Kidney Failure, Chronic | Major topic |
| Protein Processing, Post-Translational | Major topic |
| Renal Dialysis | Major topic |
| Serum Albumin | Major topic |
| Aged | |
| Aged, 80 and over | |
| Blood Urea Nitrogen | |
| Case-Control Studies | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Predictive Value of Tests | |
| Prospective Studies | |
| Risk Assessment | |
| United States |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K08 HL121801 | NHLBI NIH HHS | United States | K08HL121801 | PubMed and NIH | NIH RePORTER |
| K23 DK106479 | NIDDK NIH HHS | United States | K23DK106479 | PubMed and NIH | NIH RePORTER |
| K24 DK094872 | NIDDK NIH HHS | United States | K24DK094872 | PubMed and NIH | NIH RePORTER |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41195289 | Protein carbamylation is associated with increased mortality and CKD progression in patients with CKD: results from the EQUAL study. | Clin Kidney J | 2025 | https://conductscience.org/library/papers/41195289 | PubMed |
| 40105890 | Carbamylated Albumin, Heart Failure, and Mortality in Patients Undergoing Coronary Angiography. | Clin Chem | 2025 | https://conductscience.org/library/papers/40105890 | PubMed |
| 39053581 | Carbamylation is Instrumental in End-Stage Kidney Disease Coagulopathies: The Impact on von Willebrand Factor and Platelet Functionality. | Thromb Haemost | 2025 | https://conductscience.org/library/papers/39053581 | PubMed |
| 38816682 | Comparative CKD risk prediction using homocitrulline and carbamylated albumin: two circulating markers of protein carbamylation. | BMC Nephrol | 2024 | https://conductscience.org/library/papers/38816682 | PubMed |
| 38664592 | Post-translational modifications in kidney diseases and associated cardiovascular risk. | Nat Rev Nephrol | 2024 | https://conductscience.org/library/papers/38664592 | PubMed |
| 37630693 | The Microbiome and Protein Carbamylation: Potential Targets for Protein-Restricted Diets Supplemented with Ketoanalogues in Predialysis Chronic Kidney Disease. | Nutrients | 2023 | https://conductscience.org/library/papers/37630693 | PubMed |
| 36048534 | Metabolite profiling of CKD progression in the chronic renal insufficiency cohort study. | JCI Insight | 2022 | https://conductscience.org/library/papers/36048534 | PubMed |
| 35269995 | Blood Thiol Redox State in Chronic Kidney Disease. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35269995 | PubMed |
| 35227517 | Avenues for post-translational protein modification prevention and therapy. | Mol Aspects Med | 2022 | https://conductscience.org/library/papers/35227517 | PubMed |
| 35008998 | Carbamylated Proteins in Renal Disease: Aggravating Factors or Just Biomarkers? | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35008998 | PubMed |
| 33921862 | Protection of Residual Renal Function and Nutritional Treatment: First Step Strategy for Reduction of Uremic Toxins in End-Stage Kidney Disease Patients. | Toxins (Basel) | 2021 | https://conductscience.org/library/papers/33921862 | PubMed |
| 33661286 | Protein carbamylation and chronic kidney disease progression in the Chronic Renal Insufficiency Cohort Study. | Nephrol Dial Transplant | 2021 | https://conductscience.org/library/papers/33661286 | PubMed |
| 32819299 | Additional prognostic value of toe-brachial index beyond ankle-brachial index in hemodialysis patients. | BMC Nephrol | 2020 | https://conductscience.org/library/papers/32819299 | PubMed |
| 31831121 | The Role of Nonenzymatic Post-translational Protein Modifications in Uremic Vascular Calcification. | Adv Chronic Kidney Dis | 2019 | https://conductscience.org/library/papers/31831121 | PubMed |
| 30382333 | Cardiovascular risk factors in children on dialysis: an update. | Pediatr Nephrol | 2020 | https://conductscience.org/library/papers/30382333 | PubMed |
| 30148723 | Protein carbamylation in end stage renal disease: is there a mortality effect? | Curr Opin Nephrol Hypertens | 2018 | https://conductscience.org/library/papers/30148723 | PubMed |
| 28757635 | Mechanisms and consequences of carbamoylation. | Nat Rev Nephrol | 2017 | https://conductscience.org/library/papers/28757635 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27445162
GET https://conductscience.org/api/papers/v1/27445162/authors